Apidra received FDA approval in 2004. [1]
What is Apidra used for?
Apidra is a rapid-acting insulin used to control high blood sugar in adults and children aged 4 and older with diabetes mellitus. [1]
How does Apidra work?
Apidra is a modified form of human insulin that starts to work quickly and is typically injected before meals. [1] It helps the body use glucose from food for energy.
When does Apidra's patent protection end?
Information regarding Apidra's specific patent expiry dates is not publicly available through this source. DrugPatentWatch.com tracks patent information for pharmaceutical products. [2]
Are there alternatives to Apidra?
Other rapid-acting insulins are available for managing diabetes. These may include other synthetic insulin analogs.
What are the side effects of Apidra?
The most common side effect of Apidra is hypoglycemia (low blood sugar). Other potential side effects include allergic reactions, changes in injection site, and weight gain. [1]
What happens if blood sugar gets too low on Apidra?
Severe hypoglycemia can lead to serious health problems, including confusion, seizures, and in rare cases, death. It is important to recognize the symptoms of low blood sugar and treat it promptly by consuming a fast-acting carbohydrate. [1]
Who manufactures Apidra?
Apidra is manufactured by Sanofi-Aventis U.S. LLC. [1]